info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Relapsed and Refractory Multiple Myeloma Treatment Market Relapsed and Refractory Multiple Myeloma (RRMM) Treatment Market By Treatment Modality (Immunomodulatory Drugs, Proteasome Inhibitors, Monoclonal Antibodies, CAR-T Cell Therapy, Bispecific Antibodies); By Line of Therapy (Second-Line Therapy, Third-Line and Beyond); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Relapsed And Refractory Multiple Myeloma Treatment Market will witness a robust CAGR of 7.4% , valued at $16.8 billion in 2024 , and is expected to appreciate ... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Ovarian Cancer Drugs Market By Drug Type (Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Drugs); By Treatment Approach (First-Line Treatment, Second-Line Treatment, Adjuvant Therapy); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ovarian Cancer Drugs Market will witness a robust CAGR of 7.6% , valued at $5.3 billion in 2024 , and is projected to reach $9.2 billion by 2030 , confi... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Tuberculosis Therapeutics Market By Drug Class (First-Line Therapy, Second-Line Therapy); By Disease Type (Active TB, Latent TB); By Route of Administration (Oral, Injectable); By Distribution Channel (Public Programs, Hospital Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tuberculosis Therapeutics Market will witness a steady CAGR of 6.1% , valued at $1.34 billion in 2024 , and is expected to reach $1.91 billion by 2030 , confirms Strategic M... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Iron Deficiency Anemia Therapy Market By Therapy Type (Oral Iron Supplements, Intravenous Iron Therapy, Erythropoiesis-Stimulating Agents); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Clinics, Homecare, Specialty Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Iron Deficiency Anemia Therapy Market will witness a robust CAGR of 8.1% , valued at USD 3.9 billion in 2024 , expected to appreciate and reach USD 6.2 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Herpes Simplex Virus Treatment Market by Treatment Type (Antiviral Drugs, Vaccines); By Type of Infection (HSV-1, HSV-2); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Herpes Simplex Virus ( HSV ) Treatment Market is poised for significant growth, expected to grow at a CAGR of 5.7% valued at USD 9.8 billion 2024 , reaching a ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Substance Abuse Treatment Market By Treatment Type (Medication-Assisted Treatment, Behavioral Therapies & Counseling, Residential/Inpatient Treatment, Outpatient Treatment Programs); By Substance Type (Alcohol Dependence, Opioid Dependence, Cannabis Use Disorder, Cocaine and Stimulant Addiction, Prescription Drug Abuse, Others); By End User (Hospitals, Specialty Rehabilitation Centers, Private Clinics and Individual Practitioners, Government & Community Organizations, Telehealth and Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Substance Abuse Treatment Market will witness a robust CAGR of 6.8% , valued at $21.3 billion in 2024 , expected to appreciate and reach $31.7 billion by 2030 , confirms Str... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Non-Hodgkin Lymphoma (NHL) Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Stem Cell Transplantation); By Indication (B-cell NHL, T-cell NHL); By End-User (Hospitals, Oncology Clinics, Research Centers, Outpatient Treatment Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Market Segmentation And Forecast Scope

The Non-Hodgkin Lymphoma (NHL) Therapeutics Market is highly dynamic, with multiple therapeutic approaches and treatment options catering to various subtypes of the disease. The market is segmented bas... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Tourette Syndrome Treatment Market By Treatment Type (Pharmacological Treatments, Behavioral Therapy, Surgical Interventions); By Drug Class (Antipsychotic Drugs, Alpha-2 Adrenergic Agonists, Anticonvulsants, Others); By End User (Hospitals & Clinics, Specialty Care Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tourette Syndrome Treatment Market is expected to witness a robust compound annual growth rate (CAGR) of 6.5% , with a market value of USD 1.2 billion in 2024 , and i... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Retinoblastoma Treatment Market By Treatment Type (Chemotherapy, Radiation Therapy, Surgery, Targeted Therapy, Gene Therapy); By Disease Stage (Localized, Metastatic); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Retinoblastoma Treatment Market is projected to experience significant growth, driven by ongoing advancements in medical technology, early diagnosis, and increasing awareness of the condition. Retinobl... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Pseudomonas Aeruginosa Infection Treatment Market By Drug Class (Beta-lactam Antibiotics, Aminoglycosides, Fluoroquinolones, Biologics, Phage Therapy, Combination Therapies); By Route of Administration (Injectable, Oral, Inhaled, Topical); By Indication Type (HAP & VAP, UTIs, BSIs, Cystic Fibrosis, Surgical Site Infections); By End User (Hospitals, Clinics, Outpatient, Military Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pseudomonas Aeruginosa Infection Treatment Market will witness a promising CAGR of 7.2% , valued at USD 5.8 billion in 2024 , and is expected to reach around USD 9.4 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Sarcoma Drugs Market By Drug Type (Chemotherapy, Targeted Therapy, Immunotherapy); By Therapeutic Approach (Adjuvant, Neoadjuvant); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sarcoma Drugs Market is projected to witness a steady growth rate, with an anticipated CAGR of 7.3% from 2024 to 2030. Valued at $2.5 billion in 2024, it is expected to reac... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Malignant Glioma Therapeutics Market By Therapeutic Type (Chemotherapy, Immunotherapy, Targeted Therapy); By Drug Class (Chemotherapeutic Agents, Monoclonal Antibodies, Immunomodulatory Agents); By End User (Hospitals, Specialized Oncology Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Malignant Glioma Therapeutics Market will witness a robust growth trajectory, with a projected compound annual growth rate ( CAGR ) of 8.5% . Valued at $1.5 billion in 20... Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Glioblastoma Multiforme Treatment Market By Treatment Type (Surgical Procedures, Chemotherapy, Radiation Therapy, Targeted Therapies, Immunotherapies); By End-User (Hospitals, Clinics, Research Centers, Oncology Centers); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Glioblastoma Multiforme ( GBM ) Treatment Market is anticipated to exhibit robust growth over the forecast period from 2024 to 2030. Glioblastoma multiforme is a highly aggr... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Peripheral T-cell Lymphoma (PTCL) Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation); By Disease Subtype (PTCL-NOS, AITL, ALCL, Others); By Route of Administration (Oral, Injectable); By End User (Hospitals, Cancer Specialty Clinics, Academic & Research Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral T -Cell Lymphoma (PTCL) Treatment Market will witness a robust CAGR of 7.4%, valued at $1.61 billion ... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Graft Versus Host Disease (GVHD) Treatment Market By Treatment Type (Corticosteroids, Monoclonal Antibodies, JAK Inhibitors, Calcineurin Inhibitors, Extracorporeal Photopheresis, Others); By Disease Type (Acute GVHD, Chronic GVHD); By Route of Administration (Oral, Intravenous, Topical); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Graft Versus Host Disease (GVHD) Treatment Market will witness a robust CAGR of 9.1% , valued at $3.2 billion in 2024 , and is expected t... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Scleroderma Therapeutics Market By Drug Class (Immunosuppressants, Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Others); By Route of Administration (Oral, Parenteral, Topical); By Disease Type (Localized Scleroderma, Systemic Scleroderma, SSc-PAH, Renal Involvement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Scleroderma Therapeutics Market will witness a robust CAGR of 6.6% , valued at $3.42 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Neglected Tropical Disease (NTD) Treatment Market Neglected Tropical Disease Treatment Market By Drug Type (Antiparasitic, Antibacterial, Antiviral, Supportive Therapies, Vaccines); By Disease Type (Leishmaniasis, Chagas Disease, Lymphatic Filariasis, Schistosomiasis, Onchocerciasis, Others); By Route of Administration (Oral, Parenteral, Topical, Inhalational); By Distribution Channel (Government Programs, Hospitals, Pharmacies, NGOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neglected Tropical Disease Treatment Market will witness a robust CAGR of 8.9% , valued at $2.78 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Hairy Cell Leukemia Market By Treatment Modality (Purine Analogs, BRAF Inhibitors, Monoclonal Antibodies, Other Combination Therapies); By Diagnostic Technology (Flow Cytometry, Molecular Testing, Immunohistochemistry); By End User (Specialty Oncology Centers, Academic & Research Hospitals, Community Hematology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hairy Cell Leukemia Market will witness a robust CAGR of 7.23 % , valued at $0.78 billion in 2024 , exp... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

NUT Midline Carcinoma Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Route of Administration (Oral, Intravenous, Others); By Diagnostic Method (IHC, FISH, NGS, PCR); By End User (Hospitals & Academic Medical Centers, Specialty Cancer Clinics, Diagnostic Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global NUT Midline Carcinoma Treatment Market will witness a robust CAGR of 16.3%, valued at around $48.2 million in 2024,... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Skeletal Dysplasia Market By Type of Disorder (Achondroplasia, Hypophosphatasia, Osteogenesis Imperfecta, Thanatophoric Dysplasia, Others); By Treatment Modality (Pharmacological Therapy, Surgical Intervention, Gene Therapy, Assistive Devices); By Diagnostic Technique (Radiographic Imaging, Genetic Testing, Prenatal Diagnosis); By End User (Hospitals, Specialized Clinics, Diagnostic Labs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Skeletal Dysplasia Market will witness a robust CAGR of 7.8% , valued at $2.14 billion in 2024 , and is expected to appreciate and reach $3.37 bil... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Antisense and RNAi Therapeutics Market By Therapeutic Type (Antisense Oligonucleotides, RNA Interference); By Application (Genetic Disorders, Oncology, Neurodegenerative Diseases, Ophthalmology, Infectious Diseases); By Route of Administration (Intravenous, Subcutaneous, Intrathecal, Others); By End User (Biopharmaceutical Companies, Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antisense And RNAi Therapeutics Market will witness a robust CAGR of 17.4% , valued at $5.8 billion in 2024 , expected t... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Acute Lymphocytic Lymphoblastic Leukemia Therapeutics Market Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Oncology Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market will witness a robust CAGR of 8.7% , valued at $3.5 Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Estrogen Receptor Positive (ER+) Breast Cancer Treatment Market By Drug Class (SERMs, Aromatase Inhibitors, SERDs, CDK4/6 Inhibitors, PI3K/AKT/mTOR Inhibitors, Others); By Line of Therapy (Adjuvant, Neoadjuvant, Metastatic/Advanced); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Estrogen Receptor Positive (ER +) Breast Cancer Treatment Market will witness a robust CAGR of 6.5 % , ... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Artemisinin Combination Therapy Market By Drug Combination Type (Artemether-Lumefantrine, Artesunate-Amodiaquine, DHA-Piperaquine, Artesunate-Mefloquine, Others); By Route of Administration (Oral, Parenteral, Rectal Suppositories); By End User (Public Health Systems, Private Hospitals, NGOs, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Artemisinin Combination Therapy Market will witness a robust CAGR of 6.8% , valued at $2.42 billion in 2024 , and is expected to appreciate and reach $3.6 billion ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Periodontal Therapeutics Market By Product Type (Systemic Antibiotics, Local Antibiotic Delivery Agents, Anti-inflammatory Agents, Regenerative Therapeutics, Host Modulation Agents, Others); By Mode of Administration (Oral, Injectable, Topical); By End User (Dental Clinics, Hospitals, Academic & Research Institutions, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Periodontal Therapeutics Market will witness a robust CAGR of 6.5% , valued at $8.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Fabry Disease Treatment Market By Treatment Type (Enzyme Replacement Therapy, Pharmacological Chaperones, Gene Therapy, Substrate Reduction Therapy); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Infusion Centers, Specialty Clinics & Genetic Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Fabry Disease Treatment Market will witness a robust CAGR of 11.4% , valued at $2.15 billion in 2024, expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Cystic Fibrosis Therapeutics Market By Drug Type (CFTR Modulators, Antibiotics, Mucolytics, Others); By Route of Administration (Oral, Inhalation, Injectables); By End User (Hospitals, Pharmacies, Home Care, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cystic Fibrosis Therapeutics Market is positioned to grow at a robust CAGR of 8.5% , valued at $5.4 billion in 2024 , and is expected to ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Irritable Bowel Syndrome Treatment Market By Product Type (Prescription Drugs, Over-the-Counter Drugs, Probiotics, Digital Therapeutics); By IBS Subtype (IBS-C, IBS-D, IBS-M, IBS-U); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Telehealth Platforms); By End User (Hospitals, Gastroenterology Clinics, ASCs, Self-care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Irritable Bowel Syndrome (IBS) Treatment Market will witness a robust CAGR of 9.1% , valued at $3.84 billion in 2024 , expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Attention Deficit Hyperactivity Disorder (ADHD) Market By Drug Type (Stimulants, Non-Stimulants); By Demographic Group (Children and Adolescents, Adults); By Route of Administration (Oral, Transdermal, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Attention Deficit Hyperactivity Disorder (ADHD) Market will witness a robust CAGR of 7.5 %, valued at $19.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Primary Immunodeficiency Market By Disease Type (Antibody Deficiencies, Combined Immunodeficiencies, Phagocytic Cell Disorders, Complement Deficiencies, Others); By Treatment Type (Immunoglobulin Replacement Therapy, Targeted Biologics, Hematopoietic Stem Cell Transplantation, Gene Therapy, Supportive Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By End User (Hospitals & Specialty Clinics, Homecare Settings, Research & Academic Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Primary Immunodeficiency Market is projected to witness a robust CAGR of 7.8% , valued at USD 8.9 billion in 2024, and expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Thalassemia Market By Type (Alpha Thalassemia, Beta Thalassemia); By Treatment (Blood Transfusion, Iron Chelation Therapy, Gene Therapy, Bone Marrow/Stem Cell Transplantation, Others); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thalassemia Market will witness a steady CAGR of 8.5%, valued at $1.89 billion in 2024 , and is expected to expand and reach $Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Pediatric Diabetes Therapeutics Market By Type (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus); By Therapeutic Modality (Insulin Therapy, Oral Hypoglycemics, Adjunctive Therapies, CGM Systems, Insulin Delivery Devices); By Route of Administration (Injectable, Oral, Transdermal); By End User (Hospitals, Pediatric Specialty Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Diabetes Therapeutics Market will witness a robust CAGR of 8.5 % , valued at $12.6 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Enzyme Replacement Therapy Market By Product Type (Agalsidase Beta, Imiglucerase, Velaglucerase Alfa, Alglucosidase Alfa, Idursulfase, Others); By Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidoses, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Enzyme Replacement Therapy (ERT) Market will witness a strong CAGR of 7.3%, valued at approximately $11.8 billion in 2024 , and is p... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Fungal Keratitis Treatment Market By Treatment Type (Topical Antifungal Therapy, Systemic Antifungal Therapy, Surgical Interventions, Adjunct Therapies); By Route of Administration (Topical, Oral, Intravenous, Ocular Injections); By End User (Hospitals, Specialty Eye Clinics, Academic and Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fungal Keratitis Treatment Market will witness a robust CAGR of 6.3 % , valued at USD 1.14 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Central Nervous System (CNS) Therapeutics Market By Drug Class (Small Molecule Drugs, Biologics and Advanced Therapies); By Indication (Neurodegenerative Diseases, Psychiatric Disorders, Epilepsy and Seizure Disorders, Multiple Sclerosis, Pain Management and Neuropathic Pain); By Route of Administration (Oral, Injectable, Transdermal/Others); By End User (Hospitals & Specialty Clinics, Retail & Online Pharmacies, Research & Academic Institutes, Mental Health Centers, Military & Veteran Health Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Central Nervous System (CNS) Therapeutics Market will witness a robust CAGR of 8.6 % , valued at USD 138.2 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Idiopathic Pulmonary Fibrosis Treatment Market By Drug Type (Antifibrotic Agents, Corticosteroids, Immunosuppressants, Others); By Mechanism of Action (TGF-β Inhibition, Tyrosine Kinase Inhibition, Anti-inflammatory Modulation, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Idiopathic Pulmonary Fibrosis Treatment Market will witness a robust CAGR of 7.8% , valued at $3.1 billion in 2024 , expected to appreciate and reach $5.2 billion ... Read More

Published Date: OCT-2025 | No Of Pages:199 | $ 4485

Crohn’s Disease Therapeutics Market By Drug Class (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Small Molecule Therapies, Others); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Crohn’s Disease Therapeutics Market will witness a robust CAGR of 6.8% , valued at $14.2 billion in 2024 , and is expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Type 2 Diabetes Mellitus Treatment Market By Drug Class (Insulin Therapy, Oral Hypoglycemic Agents, GLP-1 Receptor Agonists, Dual Agonists); By Route of Administration (Oral, Injectable, Inhaled); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Type 2 Diabetes Mellitus Treatment Market will witness a robust CAGR of 8.23 % , valued at approximately USD 58.5 billion in... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Urinary Incontinence Therapeutics Market By Drug Class (Anticholinergics, Beta-3 Adrenergic Agonists, Botulinum Toxin, Topical Estrogen Therapy, Others); By Disease Type (Stress Urinary Incontinence, Urge Urinary Incontinence/Overactive Bladder, Mixed Urinary Incontinence, Overflow Incontinence); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Urinary Incontinence Therapeutics Market will witness a robust CAGR of 5.8% , valued at $4.01 billion in 2024 , and is expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Ankylosing Spondylitis Market By Drug Class (TNF Inhibitors, Interleukin Inhibitors, JAK Inhibitors, NSAIDs & Conventional DMARDs); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ankylosing Spondylitis Market will witness a robust CAGR of 7.4% , valued at $6.9 billion in 2024, expected to appreciate and reach around $10.6 billion <... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Thyroid Gland Disorder Treatment Market By Treatment Type (Hormone Replacement Therapy, Antithyroid Medication, Radioactive Iodine Therapy, Surgery, Targeted Biologics); By Indication (Hypothyroidism, Hyperthyroidism, Thyroid Cancer, Other Disorders); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thyroid Gland Disorder Treatment Market will witness a robust CAGR of 6.4% , valued at approximately USD 3.9 billion in 2024 , expected to appreciate and reach USD... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Castrate-Resistant Prostate Cancer Market By Therapy Type (Hormonal Therapy, Chemotherapy, Immunotherapy, Radiopharmaceutical Therapy, Targeted Therapy); By Drug Class (Androgen Receptor Inhibitors, CYP17 Inhibitors, PARP Inhibitors, Cytotoxic Agents, Immune Checkpoint Inhibitors, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Castrate-Resistant Prostate Cancer (CRPC) Market will witness a steady CAGR of 7.9% , valued at $10.2 billion in 2024 , expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapeutics Market By Drug Type (Monoclonal Antibodies, Recombinant Fusion Proteins, Small Molecule Inhibitors, Biosimilars); By Route of Administration (Intravitreal Injection, Intravenous Infusion, Oral); By Application (Ophthalmology [AMD, DME, RVO], Oncology [Colorectal Cancer, NSCLC, RCC, Others]); By End User (Hospitals, Specialty Clinics, ASCs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anti-Vascular Endothelial Growth Factor (Anti - VEGF) Therapeutics Market will witness a robust CAGR of 7.8%Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Connective Tissue Disease Market By Disease Type (SLE, Systemic Sclerosis, Sjögren’s Syndrome, Polymyositis & Dermatomyositis, MCTD, Others); By Treatment Type (Immunosuppressants, Corticosteroids, NSAIDs, Biologics & Monoclonal Antibodies, DMARDs, Adjunctive Therapies); By Route of Administration (Oral, Intravenous, Subcutaneous, Topical); By End User (Hospitals, Specialty Clinics, Home Healthcare, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Connective Tissue Disease Market will witness a robust CAGR of 7.3%, valued at $6.12 billion in 2024 , and is expected to appreciate and reach $9.34 bill... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Breast Adenocarcinoma Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Hormonal Therapy, Immunotherapy, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals & Cancer Treatment Centers, Specialty Clinics, Ambulatory Surgical Centers, Homecare); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Breast Adenocarcinoma Treatment Market will witness a robust CAGR of 8.4% , valued at $12.7 billion in 2024 , expected to appreciate and reach $22... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Bipolar Disorder Treatment Market By Drug Class (Mood Stabilizers, Atypical Antipsychotics, Anticonvulsants, Antidepressants, Others); By Route of Administration (Oral, Parenteral, Transdermal); By End User (Hospitals, Outpatient Clinics, Private Practices, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bipolar Disorder Treatment Market will witness a robust CAGR of 6.8 % , valued at $7.4 billion in 2024 , expected to appreciate and reach $10.9 bi... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Lymphoma Treatment Market By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Stem Cell Transplantation); By Disease Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Cancer Centers, Academic and Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lymphoma Treatment Market will witness a robust CAGR of 9.3 % , valued at $12.4 billion in 2024 , and is expected to appreciate and reach... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Food Allergy Treatment Market By Treatment Type (Oral Immunotherapy, Epinephrine Auto-injectors, Biologics, Antihistamines); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By End User (Hospitals, Clinics, Allergy Specialty Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Food Allergy Treatment Market will witness a robust CAGR of 9.1% , valued at $2.41 billion in 2024 , expected to appreciate and reach $4.07 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Blastic Plasmacytoid Dendritic Cell Neoplasm Market By Treatment Type (Chemotherapy Regimens, Targeted Therapies, Immunotherapies); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals and Oncology Centers, Specialty Clinics, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blastic Plasmacytoid Dendritic Cell Neoplasm ( BPDCN ) Market will witness a robust CAGR of 8.7% , valued at USD... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Hunter Syndrome Treatment Market By Treatment Type (Enzyme Replacement Therapy, Gene Therapy, Substrate Reduction Therapy, Supportive & Symptomatic Treatment); By Route of Administration (Intravenous, Intrathecal, Oral, Others); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hunter Syndrome Treatment Market will witness a robust CAGR of 7.4% , valued at $1.21 billion in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Hepatitis Therapeutics Market By Drug Class (Direct-Acting Antivirals, Nucleos(t)ide Analogues, Immune Modulators, Combination Therapies); By Disease Type (Hepatitis B, Hepatitis C, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hepatitis Therapeutics Market will witness a robust CAGR of 6.8% valued at , $17.4 billion in 2024 , expected to appreciate and reach $25.9 billio... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Phenylketonuria (PKU) Treatment Market By Treatment Type (Medical Foods, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatments); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Phenylketonuria ( PKU ) Treatment Market will witness a robust CAGR of 6.5% , valued at $1.2 bi... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Lysosomal Acid Lipase Deficiency Treatment Market By Therapy Type (Enzyme Replacement Therapy, Gene Therapy, Adjunctive Therapies); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Specialty Clinics, Hospitals, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lysosomal Acid Lipase Deficiency Treatment Market will witness a robust CAGR of 10.4% , valued at $425 million in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Amyotrophic Lateral Sclerosis Treatment Market By Treatment Type (Medication-Based Therapy, Gene and Cell Therapy, Symptomatic Treatment); By Route of Administration (Oral, Intravenous, Subcutaneous, Others); By End User (Hospitals, Specialized Neurology Clinics, Homecare Settings, Research and Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Amyotrophic Lateral Sclerosis ( ALS ) Treatment Market will witness a robust CAGR of 8.4% , valued at $1.26 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Autoimmune Hemolytic Anemia (AIHA) Treatment Market By Treatment Type (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Blood Transfusions, Surgical Interventions, Complement Inhibitors); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Autoimmune Hemolytic Anemia ( AIHA ) Treatment Market will witness a robust CAGR of 7.1% , valued at Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485

Age-Related Macular Degeneration Market By Disease Type (Dry AMD, Wet AMD); By Drug Class (Anti-VEGF Agents, Complement Inhibitors, Gene Therapy, Others); By Route of Administration (Intravitreal, Oral, Subretinal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Age-Related Macular Degeneration ( AMD ) Market will witness a robust CAGR of 6.8% , valued at approximately $9.4 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Basal Cell Carcinoma (BCC) Treatment Market By Treatment Type (Surgical Procedures, Topical Medications, Targeted Therapies, Radiation Therapy, Immunotherapy); By Route of Administration (Topical, Oral, Intravenous); By End User (Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Basal Cell Carcinoma ( BCC ) Treatment Market will witness a robust CAGR of 6.8% , valued at $6.4 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Metabolic Disorder Therapeutics Market By Product Type (Insulin and Insulin Analogs, Enzyme Replacement Therapies, Gene Therapies, RNA-Based Therapeutics, Small Molecule Drugs, Other Biologics); By Application (Diabetes Mellitus, Obesity, Lysosomal Storage Disorders, Hypercholesterolemia and Dyslipidemia, Other Metabolic Disorders); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metabolic Disorder Therapeutics Market will witness a robust CAGR of 7.4% , valued at USD 72.6 billion in 2024 , expected to appreciate and reach USD 112.5 billion... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Allergy Immunotherapy Market By Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy); By Allergy Type (Allergic Rhinitis, Asthma, Venom Allergy, Food Allergy, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Allergy Immunotherapy Market will witness a robust CAGR of 11.3 % , valued at $2.49 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Osteoarthritis Therapeutics Market By Drug Class (NSAIDs, Corticosteroids, Viscosupplements, Biologics, DMOADs); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Osteoarthritis Therapeutics Market is projected to grow at a robust CAGR of 9.3 % , reaching an estimated value of $ 16.42Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Non-Alcoholic Steatohepatitis (NASH) Treatment Market By Drug Type (Vitamin E & Pioglitazone, Obeticholic Acid, Elafibranor, Selonsertib, Other Pipeline Molecules); By Mechanism of Action (Anti-fibrotic Agents, Anti-inflammatory Agents, Metabolic Modulators); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Alcoholic Steatohepatitis ( NASH ) Treatment Market will witness a robust CAGR of 19.3 % , valued at $5.2 bi... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Catastrophic Antiphospholipid Syndrome Market By Treatment Modality (Plasma Exchange, Anticoagulation Therapy, Immunosuppressive Agents, Intravenous Immunoglobulins, Complement Inhibitors); By Diagnostic Approach (ELISA, Lupus Anticoagulant Testing, Beta-2 Glycoprotein I Testing, Next-Generation Sequencing); By End User (Hospitals & Critical Care Centers, Specialty Clinics & Immunology Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Catastrophic Antiphospholipid Syndrome ( CAPS ) Market will witness a robust CAGR of 7.4% , valued at $654 million in 2024Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Rheumatoid Arthritis Therapeutics Market By Drug Class (Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs, NSAIDs, Corticosteroids); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rheumatoid Arthritis Therapeutics Market will witness a robust CAGR of 6.8% , valued at $28.4 billion in 2024 , and is expected to appreciate and reach $42.1 billi... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Guillain-Barre Syndrome Market By Treatment Type (IVIG, Plasmapheresis, Steroid Therapy, Supportive Care); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Hospitals, Neurology Clinics, ASCs, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Guillain - Barré Syndrome ( GBS ) Market will witness a robust CAGR of ... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Huntington’s Disease Treatment Market By Treatment Type (Symptomatic Treatment, Disease-Modifying Therapies); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Huntington’s Disease Treatment Market will witness a robust CAGR of 21.1% , valued at $1.3 billion in 2024 , and is expected to app... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Endometriosis Treatment Market By Treatment Type (Hormonal Therapy, Pain Management, Surgery); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endometriosis Treatment Market will witness a robust CAGR of 7.6% , valued at USD 2.45 billion in 2024, expected to appreciate and reach USD 3.82 ... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Acromegaly Treatment Market By Drug Class (Somatostatin Analogs, Growth Hormone Receptor Antagonists, Dopamine Agonists, Emerging Therapies); By Route of Administration (Injectable, Oral); By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Homecare & Tele-Endocrinology); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acromegaly Treatment Market will witness a steady CAGR of 5.8% , valued at $2.1 billion in 2024 , expected to appreciate and reach $3.1 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Acute Repetitive Seizures Market By Product Type (Intranasal Rescue Therapies, Buccal and Sublingual Formulations, Injectable Rescue Medications); By Route of Administration (Nasal, Oral/Buccal, Intramuscular/Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Repetitive Seizures Market will witness a robust CAGR of 13.1% , valued at approximately $805 million in 2024 , expected to appreciate and reach around $1.67... Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485

Postmenopausal Osteoporosis Treatment Market By Drug Class (Bisphosphonates, RANK Ligand Inhibitors, SERMs, Parathyroid Hormone Analogs, Calcitonin & Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context


The Global Postmenopausal Osteoporosis Treatment Market will witness a robust CAGR of 6.9%, valued at $14.63 billion in 2024, expected to appreciate and reach $22.42 ... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Pneumonia Therapeutics Market By Drug Class (Antibiotics, Antivirals, Antifungals, Monoclonal Antibodies, Adjunct Therapies); By Etiology (Bacterial, Viral, Fungal, Aspiration, Atypical); By Route of Administration (Oral, Intravenous, Inhalation); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pneumonia Therapeutics Market will witness a robust CAGR of 6.4 % , valued at $17.3 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Insomnia Therapeutics Market By Treatment Type (Prescription Medications [Non-benzodiazepine Hypnotics, Benzodiazepines, Melatonin Receptor Agonists, Orexin Receptor Antagonists], Over-the-Counter Sleep Aids, Digital and Behavioral Therapeutics); By Route of Administration (Oral, Transdermal, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Insomnia Therapeutics Market will witness a robust CAGR of 6.8% , valued at $4.9 billion in 2024 , expected to appreciate and reach $7.3 billion by 2030 ,... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Actinic Keratosis Treatment Market By Treatment Type (Topical Medications, Cryotherapy, Photodynamic Therapy, Laser Therapy, Others); By End User (Hospitals and Dermatology Clinics, Ambulatory Surgical Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Actinic Keratosis Treatment Market will witness a robust CAGR of 6.8% , valued at $7.2 billion in 2024 , and is expected to appreciate an... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Paroxysmal Nocturnal Hemoglobinuria Market By Drug Type (C5 Inhibitors, C3 Inhibitors, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Market will witness a robust CAGR of 9.7 % ,... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Hemophilia Treatment Market By Product Type (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factors, Non-Factor Replacement Therapies, Gene Therapy); By Disease Type (Hemophilia A, Hemophilia B, Others); By Treatment Approach (On-Demand Therapy, Prophylactic Therapy, Immune Tolerance Induction Therapy); By End User (Hospitals & Hemophilia Treatment Centers, Home Care Settings, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemophilia Treatment Market will witness a robust CAGR of 8.78 % , valued at $10.45 billionRead More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Dementia Treatment Market By Treatment Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Monoclonal Antibodies, Combination Therapies, Others); By Route of Administration (Oral, Intravenous, Transdermal); By End User (Hospitals and Memory Clinics, Homecare Settings, Long-Term Care Facilities, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dementia Treatment Market will witness a robust CAGR of 12.8% , valued at $10.45 billion in 2024 , expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Anxiety Disorder Treatment Market By Drug Class (SSRIs, SNRIs, Benzodiazepines, Beta-Blockers, Atypical Antipsychotics); By Therapy Type (CBT, Digital Therapeutics, Exposure Therapy, MBSR); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Mental Health Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anxiety Disorder Treatment Market will witness a robust CAGR of 7.8% , valued at $12.4 billion in 2024 , and is expected to appreciate and reach $19.6 billion by 2... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Myeloproliferative Disorder Treatment Market By Disorder Type (PV, ET, PMF); By Treatment (JAK Inhibitors, Chemotherapy, Stem Cell Transplantation); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital, Retail, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myeloproliferative Disorder Treatment Market is expected to witness a steady CAGR of 6.9% , valued at $5.4 billion in 2024 , and projected to reach $8.1 billion by... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Pancreatic Cancer Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiotherapy, Others); By Disease Stage (Localized, Locally Advanced, Metastatic); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pancreatic Cancer Treatment Market will witness a robust CAGR of 11.8% , valued at USD 6.4 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Anterior Uveitis Treatment Market By Treatment Type (Corticosteroids, Cycloplegics, Biologics, Immunosuppressants, NSAIDs); By Route of Administration (Topical, Oral, Parenteral, Implants); By End User (Hospitals, Specialty Clinics, ASCs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anterior Uveitis Treatment Market will witness a robust CAGR of 6.9% , valued at $494.7 million in 2024 , expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Gastroesophageal Reflux Disease Therapeutics Market By Drug Class (PPIs, H2 Receptor Antagonists, Antacids, Prokinetics, Mucosal Protectants); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market is projected to grow at a robust CAGR of 5.7% , increasing from USD 7.... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Inflammatory Bowel Disease (IBD) Treatment Market By Drug Class (Biologics [TNF-alpha Inhibitors, Integrin Inhibitors, Interleukin Inhibitors], Small Molecules [JAK Inhibitors, S1P Receptor Modulators], 5-ASA Derivatives, Corticosteroids, Immunomodulators, Others); By Disease Type (Crohn’s Disease, Ulcerative Colitis); By Route of Administration (Oral, Injectable, Rectal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inflammatory Bowel Disease (IBD) Treatment Market will witness a robust CAGR of 6.9% , valued at $24.8 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Metastatic Lung Adenocarcinoma Treatment Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy, Combination Therapy); By Biomarker Status (EGFR Mutation, ALK Rearrangement, KRAS Mutation, PD-L1 Expression, Wild-Type); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metastatic Lung Adenocarcinoma Treatment Market will witness a robust CAGR of 9.2% , valued at $12.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Neuroendocrine Tumor (NET) Treatment Market By Treatment Type (Somatostatin Analogs, Targeted Therapy, PRRT, Chemotherapy, Immunotherapy, Surgery); By Indication (GI NETs, Pancreatic NETs, Lung NETs, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neuroendocrine Tumor (NET) Treatment Market will witness a robust CAGR of 8.7% , value... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Transthyretin Amyloidosis Treatment Market By Drug Type (RNA Interference, Antisense Oligonucleotides, TTR Stabilizers, Supportive Therapies); By Route of Administration (Intravenous, Oral, Others); By End User (Hospitals & Specialty Clinics, Outpatient & Home Care, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Transthyretin Amyloidosis Treatment Market will witness a robust CAGR of 13.8% , valued at USD 2.1 billion in 2024, expe... Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Infectious Disease Therapeutics Market By Product Type (Antiviral Drugs, Antibacterial Drugs, Antifungal and Antiparasitic Drugs, Monoclonal Antibodies and Immunotherapies); By Indication (HIV/AIDS, Hepatitis, Influenza, Tuberculosis, Malaria, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Infectious Disease Therapeutics Market will witness a robust CAGR of 7.4% , valued at approximately $145.6 billion in 2024 , and is expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Sepsis Therapeutics Market By Drug Class (Antibiotics & Antimicrobials, Immunomodulators & Biologics, Adjuvant Therapies); By Pathogen Type (Gram-Negative Bacteria, Gram-Positive Bacteria, Fungal Infections); By Route of Administration (Intravenous, Oral); By End User (Hospitals & ICUs, Specialty Clinics & Research Institutions, Military & EMS); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sepsis Therapeutics Market will witness a robust CAGR of 8.4% , valued at $5.1 billion in 2024 , expected to appreciate and reach $8.3 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Polycystic Ovarian Syndrome (PCOS) Treatment Market By Drug Class (Hormonal Contraceptives, Insulin Sensitizers, Anti-Androgens, Fertility Agents, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Polycystic Ovarian Syndrome ( PCOS ) Treatment Market will witness a robust CAGR of 6.8% , valued at approximately $5.2 billionRead More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Alopecia Treatment Market By Product Type (Pharmaceuticals, Procedural Treatments, Cosmeceuticals & OTC Products); By Gender (Male, Female); By Distribution Channel (Dermatology Clinics & Hospitals, Aesthetic Clinics, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alopecia Treatment Market will witness a robust CAGR of 6.8% , valued at $10.4 billion in 2024, expected to appreciate and reach $15.4 billionRead More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Celiac Disease Treatment Market By Drug Class (Enzyme Therapies, Tight Junction Modulators, Immune Modulators, Medical Foods & Supplements); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Celiac Disease Treatment Market will witness a robust CAGR of 8.5% , valued at USD 1.35 billion in 2024 , expected to appreciate and reach USD 2.2... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Post-Traumatic Stress Disorder Treatment Market By Treatment Type (Pharmacological Therapy, Non-Pharmacological Therapy, Combination Therapy); By Therapeutic Class (SSRIs, Antipsychotics, Beta-Blockers, Benzodiazepines, Others); By End User (Hospitals & Clinics, Mental Health Institutions, Military & Veterans Affairs Facilities, Digital Therapy Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Post-Traumatic Stress Disorder ( PTSD ) Treatment Market will witness a robust CAGR of 6.9% , valued at $8.4 billion in 2024 , and is exp... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Prostate Cancer Therapeutics Market By Therapy Type (Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Radiopharmaceuticals); By Stage (Localized, Advanced/Metastatic, Castration-Resistant); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prostate Cancer Therapeutics Market will witness a robust CAGR of 9.8 % , valued at $17.8 billion in 2024 , and is expected to appreciate... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Ulcerative Colitis Treatment Market By Drug Class (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, JAK Inhibitors, Others); By Disease Type (Mild, Moderate, Severe); By Route of Administration (Oral, Injectable, Rectal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ulcerative Colitis Treatment Market is projected to witness a robust CAGR of 6.3% , valued at $7.9 billion in 2024 , and is expected to appreciate and reach $11.4 ... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Peptide Therapeutics Market By Type (Innovative Peptides, Generic Peptides); By Route of Administration (Parenteral, Oral, Others); By Application (Metabolic Disorders, Cancer, Cardiovascular Diseases, Infectious Diseases, Gastrointestinal Disorders, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Therapeutics Market will witness a robust CAGR of 7.8% , valued at $ 32.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Dry Eye Syndrome Treatment Market By Product Type (Artificial Tears, Anti-Inflammatory Drugs, Secretagogues, Autologous Serum Eye Drops, Punctal Plugs, Devices); By Disease Type (Evaporative, Aqueous Deficient, Mixed); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dry Eye Syndrome Treatment Market will witness a robust CAGR of 8.4 % , valued at $ 7.5 billion in 2024 , and is ex... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Non-Small Cell Lung Cancer Therapeutics Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy & Others); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Small Cell Lung Cancer Therapeutics Market will witness a robust CAGR of 9.4% , valued at $23.8 billion in 2024 , expected to appreciate and reach $40.8 billio... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Acute Myeloid Leukemia Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Others); By Route of Administration (Oral, Injectable); By End User (Hospitals, Specialty Cancer Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Myeloid Leukemia Treatment Market will witness a strong CAGR of 11.2 %, valued at $ 5.3Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Microbiome Therapeutics Market By Product Type (Live Biotherapeutic Products, Prebiotics & Postbiotics, Fecal Microbiota Transplantation); By Application (Gastrointestinal Disorders, Oncology, Metabolic Diseases, Neurological Disorders, Autoimmune Conditions); By Route of Administration (Oral, Rectal, Enteric-Coated, Others); By End User (Hospitals, Academic Institutions, Biotech Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microbiome Therapeutics Market will witness a robust CAGR of 31.8% , valued at $1.67 billion in 2024 , and is expected to appreciate and reach $10.83 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Duodenal Ulcer Treatment Market By Drug Class (Proton Pump Inhibitors, H2 Receptor Antagonists, Antibiotics, Protective Agents); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Duodenal Ulcer Treatment Market will witness a robust CAGR of 7.2 % valued at USD 4.3 billion in 2024 , expected to appreciate and reach USD 6.1 b... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Cerebral Infarction Treatment Market By Treatment Type (Pharmacological Interventions [Thrombolytics, Antiplatelet Agents, Anticoagulants, Neuroprotective Agents], Surgical Procedures [Mechanical Thrombectomy, Carotid Endarterectomy, Decompressive Hemicraniectomy], Supportive and Adjunctive Care); By Mode of Administration (Intravenous, Oral, Intra-Arterial); By End User (Hospitals and Stroke Centers, Ambulatory Surgical Centers, Specialty Neurology Clinics, Rehabilitation Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cerebral Infarction Treatment Market will witness a robust CAGR of 9.35 % , valued at approximately USD 9.4 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Acinetobacter Pneumonia Therapeutics Market By Drug Class (β-lactams, Polymyxins, Carbapenems, Sulbactam Combinations, Novel Agents); By Route of Administration (Intravenous, Oral, Inhalation); By End User (Hospitals, ICUs, ASCs, Military Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acinetobacter Pneumonia Therapeutics Market will witness a promising CAGR of 7.6% , valued at $1.12 billion in 2024 , and is projected to... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485